This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • An Open-Label Phase I/IIa Study of the Safety and ...
Clinical trial

An Open-Label Phase I/IIa Study of the Safety and Efficacy of Melphalan-flufenamide (Melflufen) and Dexamethasone Combination for Patients with Relapsed and/or Relapsed-Refractory Multiple Myeloma

Read time: 1 mins
Last updated:25th Feb 2013
Phase I: The primary objective of the Phase I portion of the study is to determine the MTD of the combination of melflufen and dexamethasone in patients with relapsed and/or relapsed-refractory multiple myeloma. Phase IIa: To evaluate the objective response rate (including minimal response [MR]) to the combination of melflufen and dexamethasone at the MTD determined in Phase I.
Category Value
Study start date 2013-02-25

View full details